Search research articles
Contact Us
Filters
Showing results (1-10 of 179) with videos related to
Page
of 18
Sort By:
Evidence-Based Medicine
|
May 4, 2010
Cost-effectiveness analysis: Compared with glyburide, sitagliptin associated with incremental cost-effectiveness ratio of $169,572 per QALY and exenatide with $278,935 per QALY as second-line treatment in adult diabetics in the USA
Wendy A Davis
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 5, 2026
Incidence and associates of aortic valve replacement in people with or without type 2 diabetes: The Fremantle diabetes study phase II
Timothy M E Davis, Wendy A Davis
Cardiovascular Diabetology
|
September 16, 2023
Temporal trends in chronic complications of diabetes by sex in community-based people with type 2 diabetes: the Fremantle Diabetes Study
Wendy A Davis, Timothy M E Davis
Diabetes, Obesity & Metabolism
|
December 11, 2023
An assessment of factors contributing to the decline in risk of stroke complicating type 2 diabetes: The Fremantle Diabetes Study
Timothy M E Davis, Wendy A Davis
Diabetes Care
|
January 30, 2007
An assessment of eligibility for inhaled insulin (Exubera): the Fremantle Diabetes Study
Timothy M E Davis, Wendy A Davis
Internal Medicine Journal
|
July 25, 2022
The relationship between pancreatic cancer and type 2 diabetes: the Fremantle Diabetes Study Phase I
Timothy M E Davis, Wendy A Davis
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 18, 2026
Refining insights on type 2 diabetes and aortic valve replacement-reply to Liu et al
Timothy M E Davis, Wendy A Davis
Internal Medicine Journal
|
March 10, 2025
Incidence and predictors of transurethral resection of prostate in men with and without type 2 diabetes: the Fremantle Diabetes Study Phase I
Timothy M E Davis, Wendy A Davis
Diabetes Research and Clinical Practice
|
October 19, 2010
Cardiovascular risk prediction in adults with type 1 diabetes: the Fremantle Diabetes Study
Wendy A Davis, Timothy M E Davis
Diabetes Care
|
July 4, 2020
Influence of Renin-Angiotensin System Inhibitors on Lower-Respiratory Tract Infections in Type 2 Diabetes: The Fremantle Diabetes Study Phase II
Timothy M E Davis, Wendy A Davis
Page
of 18
Search research articles
Search
Showing results (1-10 of 179) with videos related to
Sort By:
Page
of 18
Evidence-Based Medicine
|
May 4, 2010
Cost-effectiveness analysis: Compared with glyburide, sitagliptin associated with incremental cost-effectiveness ratio of $169,572 per QALY and exenatide with $278,935 per QALY as second-line treatment in adult diabetics in the USA
Wendy A Davis
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 5, 2026
Incidence and associates of aortic valve replacement in people with or without type 2 diabetes: The Fremantle diabetes study phase II
Timothy M E Davis, Wendy A Davis
Cardiovascular Diabetology
|
September 16, 2023
Temporal trends in chronic complications of diabetes by sex in community-based people with type 2 diabetes: the Fremantle Diabetes Study
Wendy A Davis, Timothy M E Davis
Diabetes, Obesity & Metabolism
|
December 11, 2023
An assessment of factors contributing to the decline in risk of stroke complicating type 2 diabetes: The Fremantle Diabetes Study
Timothy M E Davis, Wendy A Davis
Diabetes Care
|
January 30, 2007
An assessment of eligibility for inhaled insulin (Exubera): the Fremantle Diabetes Study
Timothy M E Davis, Wendy A Davis
Internal Medicine Journal
|
July 25, 2022
The relationship between pancreatic cancer and type 2 diabetes: the Fremantle Diabetes Study Phase I
Timothy M E Davis, Wendy A Davis
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 18, 2026
Refining insights on type 2 diabetes and aortic valve replacement-reply to Liu et al
Timothy M E Davis, Wendy A Davis
Internal Medicine Journal
|
March 10, 2025
Incidence and predictors of transurethral resection of prostate in men with and without type 2 diabetes: the Fremantle Diabetes Study Phase I
Timothy M E Davis, Wendy A Davis
Diabetes Research and Clinical Practice
|
October 19, 2010
Cardiovascular risk prediction in adults with type 1 diabetes: the Fremantle Diabetes Study
Wendy A Davis, Timothy M E Davis
Diabetes Care
|
July 4, 2020
Influence of Renin-Angiotensin System Inhibitors on Lower-Respiratory Tract Infections in Type 2 Diabetes: The Fremantle Diabetes Study Phase II
Timothy M E Davis, Wendy A Davis
Page
of 18